› $150,000,000 verdict in personal injury case
A team of researchers renowned for their work in colon cancer believe they may have found a better treatment for Barrett’s esophagus and esophageal cancer based on findings from their colon cancer research, according to Science Daily.
Very low doses of inhaled carbon monoxide has been shown to reverse a serious digestive condition in diabetic mice, a finding that could give hope to millions of sufferers of diabetic gastroparesis. The findings are based on a study conducted by researchers with the Mayo Clinic and presented at last year’s Digestive Disease Week gathering.
The U.S. Fifth Circuit Court of Appeals has found in favor with a lower court that patients may sue generic drug makers under state law for failing to provide adequate warnings about potential side effects with their drugs. The ruling extends a 2009 U.S. Supreme Court ruling governing makers of name-brand drugs. The issue of whether generic drug companies should be held liable for not adequately warning consumers has divided several district courts, which can increase the odds of a Supreme Court review in the future, according to U.S. Circuit Judge Patrick Higginbotham.
An estimated 250,000 to 400,000 people in the United States suffer from Tardive Dyskinesia, a serious and disabling involuntary movement disorder. The condition was first linked to use of anti-psychotic medications but most recently has been linked to a common heartburn, GERD (gastroesophageal reflux disease) and gastroparesis medication known as Reglan (metoclopramide). How the medications cause Tardive Dyskinesia is debatable, but studies show that long-term use of medications leave users at higher risk of developing the condition.
More and more doctors are diagnosing fussy infants with gastroesophageal reflux disease, or GERD, leaving some critics worrying that doctors are over-diagnosing the condition to soothe exasperated mothers.
